The most relevant advances have come from oncology, where efforts have focused on disrupting the MLL-AF4 fusion protein or modulating AFF1-driven transcriptional complexes in acute lymphoblastic leukemia. The gene discussed is AFF1; the disease is acute lymphoblastic leukemia.